MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-23-2023
Natus Medical Incorporated Accounts Payables 2011-2026 | NTUS
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Natus Medical Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 36.4 M | 23.4 M | 27.3 M | 28.8 M | 25.2 M | 18.7 M | 23.7 M | 21.4 M | 29.8 M | 32.5 M | 16.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.4 M | 16.4 M | 25.8 M |
Quarterly Accounts Payables Natus Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 34.3 M | 36.4 M | 28.3 M | 26.9 M | 24.5 M | 23.4 M | 27.6 M | 31.7 M | 33.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M | 32.5 M | 32.5 M | 32.5 M | 32.5 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.4 M | 16.4 M | 25.8 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
234 M | $ 36.74 | - | $ 5.47 K |  USA |
 |
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.38 | - | $ 266 M | USA |
 |
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.59 | - | $ 36.7 M | USA |
 |
AdaptHealth Corp.
AHCO
|
352 M | $ 12.07 | - | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | USA |
 |
Delcath Systems
DCTH
|
2.66 M | $ 9.7 | - | $ 347 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
228 M | $ 81.19 | - | $ 47.5 B | USA |
 |
FONAR Corporation
FONR
|
1.55 M | $ 18.6 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
98.9 M | $ 88.6 | - | $ 12 B | USA |
 |
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
531 K | $ 1.9 | - | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
36.6 M | $ 54.14 | - | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.0 | - | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
113 M | $ 85.63 | - | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.94 | - | $ 374 M | USA |
 |
LENSAR
LNSR
|
19 M | $ 5.89 | -2.81 % | $ 70.4 M | USA |
 |
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | USA |
 |
Medtronic PLC
MDT
|
2.45 B | $ 86.28 | - | $ 111 B | USA |
 |
Align Technology
ALGN
|
109 M | $ 171.87 | - | $ 12.9 B | USA |
 |
Myomo
MYO
|
1.51 M | $ 0.7 | - | $ 29.3 M | USA |
 |
AxoGen
AXGN
|
2.89 M | $ 32.64 | - | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | USA |
 |
Orthofix Medical
OFIX
|
58.4 M | $ 11.77 | - | $ 466 M |  Curacao |
 |
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
34.7 M | $ 329.87 | - | $ 12.8 B | USA |
 |
Insulet Corporation
PODD
|
75 M | $ 203.5 | - | $ 14.3 B | USA |
 |
Sintx Technologies
SINT
|
382 K | $ 2.53 | 0.4 % | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
4.25 M | $ 4.13 | -0.24 % | $ 874 M | USA |
 |
Stryker Corporation
SYK
|
1.8 B | $ 332.3 | - | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
4.97 M | $ 24.57 | - | $ 562 M | USA |
 |
TELA Bio
TELA
|
2.31 M | $ 0.63 | 5.47 % | $ 29.6 M | USA |
 |
TransMedics Group
TMDX
|
10.4 M | $ 104.8 | - | $ 3.56 B | USA |
 |
Tandem Diabetes Care
TNDM
|
47.1 M | $ 19.17 | - | $ 1.3 B | USA |
 |
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | USA |